DekaBank Deutsche Girozentrale - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 152 filers reported holding REATA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 3.61 and the average weighting 0.2%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,930
+72.7%
17,0000.0%0.01%
+75.0%
Q2 2023$1,697
+12.8%
17,0000.0%0.00%0.0%
Q1 2023$1,505
+82.2%
17,000
-24.9%
0.00%
+100.0%
Q4 2022$826
-99.9%
22,6400.0%0.00%0.0%
Q3 2022$559,000
-21.3%
22,6400.0%0.00%0.0%
Q2 2022$710,000
+38.1%
22,640
+36.1%
0.00%
+100.0%
Q1 2022$514,000
+44.0%
16,640
+9.9%
0.00%0.0%
Q4 2021$357,000
-76.7%
15,140
+2.7%
0.00%
-75.0%
Q3 2021$1,529,000
-28.3%
14,7400.0%0.00%
-33.3%
Q2 2021$2,133,000
+52.0%
14,7400.0%0.01%
+20.0%
Q1 2021$1,403,000
-25.6%
14,7400.0%0.01%
-28.6%
Q4 2020$1,886,000
-66.1%
14,740
-75.6%
0.01%
-72.0%
Q3 2020$5,560,000
+424.0%
60,390
+762.7%
0.02%
+257.1%
Q2 2020$1,061,000
-17.4%
7,000
-20.5%
0.01%
-30.0%
Q1 2020$1,284,000
-18.7%
8,800
+17.3%
0.01%0.0%
Q4 2019$1,579,000
-61.9%
7,500
-83.4%
0.01%
-52.4%
Q2 2019$4,147,000
+549.0%
45,300
+512.2%
0.02%
+425.0%
Q1 2019$639,000
-45.9%
7,400
-67.3%
0.00%
-50.0%
Q4 2018$1,182,000
+85.0%
22,650
+206.1%
0.01%
+100.0%
Q3 2018$639,000
+139.3%
7,400
-2.6%
0.00%
+100.0%
Q2 2018$267,000
+75.7%
7,6000.0%0.00%
+100.0%
Q1 2018$152,0007,6000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
CPMG Inc 3,063,567$298,453,00049.63%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 150,000$14,613,00019.62%
Corriente Advisors, LLC 300,000$29,226,00014.82%
Prosight Management, LP 114,554$11,160,0005.31%
MADDEN SECURITIES Corp 43,927$4,279,0003.18%
LBJ Family Wealth Advisors, Ltd. 30,368$2,958,0002.24%
Biondo Investment Advisors, LLC 99,652$9,708,0002.10%
Cormorant Asset Management, LP 450,000$43,839,0001.69%
Duquesne Family Office 543,901$52,987,0001.54%
AWH Capital, L.P. 9,500$925,0001.30%
View complete list of REATA PHARMACEUTICALS INC shareholders